Hyperagonism of a Vitamin D Receptor Agonist/Histone Deacetylase Inhibitor Hybrid Molecule
Open Access
- 18 September 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (19) , 20675-20688
Abstract
1,25-Dihydroxyvitamin D (1,25D) analogs engage the vitamin D receptor (VDR) and can exert anticancer and immunomodulatory effects. Although tumors often resist 1,25D monotherapy, combining VDR agonism with histone deacetylase inhibitors (HDACi) restores anticancer efficacy. Here, we present AC-340, a novel bifunctional molecule that incorporates HDACi into a VDR agonist backbone. Besides its robust bifunctionality in vitro in multiple melanoma models, RNaseq analysis of B16–F10 mouse melanoma cells revealed that AC-340 superinduces the expression of a broad array of VDR target genes. Comparative structural studies and ChIP-qPCR revealed that AC-340 forms more interactions than 1,25D with residues in the VDR coactivator binding domain, leading to more efficacious recruitment of coactivator CBP. This, likely coupled with AC-340 HDACi activity, leads to elevated H3K27 acetylation of VDR target genes, a mark of active transcription. Thus, AC-340 functions as a VDR hyperagonist and should be efficacious in mono- or combination therapies against multiple cancer models.Keywords
Funding Information
- Canadian Institutes of Health Research (378751-PJT-153227)
- Agence Nationale de la Recherche (ANR-10-IDEX-0002-02, ANR-10-LABX-0030- 992)
- French Infrastructure for Integrated Structural Biology (ANR-10-INBS-05)
This publication has 59 references indexed in Scilit:
- Enzymatic activation in vitamin D signaling – Past, present and futureArchives of Biochemistry and Biophysics, 2023
- Calcipotriol, a synthetic Vitamin D analog, promotes antitumor immunity via CD4+T-dependent CTL/NK cell activationBiomedicine & Pharmacotherapy, 2022
- Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 AcetylationCell Reports, 2018
- Functions of vitamin D in boneHistochemistry and Cell Biology, 2018
- Vitamin D analogues: Potential use in cancer treatmentCritical Reviews in Oncology/Hematology, 2017
- Optimization of histone deacetylase inhibitor activity in non-secosteroidal vitamin D-receptor agonist hybridsBioorganic & Medicinal Chemistry, 2015
- Synthetically Accessible Non-Secosteroidal Hybrid Molecules Combining Vitamin D Receptor Agonism and Histone Deacetylase InhibitionChemistry & Biology, 2012
- Cytochromes P450 are essential players in the vitamin D signaling systemBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2011
- Structure-Based Design of a Superagonist Ligand for the Vitamin D Nuclear ReceptorChemistry & Biology, 2008
- The pleiotropic actions of vitamin DBioEssays, 2003